Primary sequence of the envelope glycoprotein of a dengue type 2 virus isolated from patient with dengue hemorrhagic fever and encephalopathy

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 27, Issue 2, 1996, Pages 221-227

  Sistayanarain, Anchalee ^a   Maneekarn, Niwat ^a   Polprasert, Boonsom ^a   Sirisanthana, Virat ^a   Makino, Yoshihiro ^b   Fukunaga, Toshihiko ^b   Sittisombut, Nopporn ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CHILD; CLASSIFICATION; DENGUE; DENGUE VIRUS; EPIDEMIOLOGY; GENETICS; HUMAN; MALE; MOLECULAR GENETICS; PHYLOGENY; SEROTYPING; THAILAND; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS GENOME;

AMINO ACID SEQUENCE; CHILD; DENGUE; DENGUE VIRUS; ENCEPHALITIS, VIRAL; EPIDEMIOLOGY, MOLECULAR; GENOME, VIRAL; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEROTYPING; THAILAND; VIRAL ENVELOPE PROTEINS;

EID: 0030154496     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Blok J, Gibbs AJ, McWilliam SM, Vitaratana UT. NSI gene sequences from eight dengue-2 viruses and their evolutionary relationships with other dengue-2 viruses. Arch Virol 1991; 118 : 209-23.
2. Blok J, McWilliam SM, Butler HC, et al. Comparison of a dengue-2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses. Virology 1992; 187 : 573-90.
3. Blok J, Samuel S, Gibbs AJ, Vitaratana UT. Variation of the nucleotide and encoded amino acid sequences of the envelope gene from eight dengue-2 viruses. Arch Virol 1989; 105 : 39-53.
4. Burke DS, Nisalak A, Johnson DE, McN. Scott R. A prospective study of dengue infection in Bangkok. Am J Trop Med Hyg 1989; 38 : 172-80.
5. Cecilia D, Gould EA. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 1991; 181 : 70-7.
6. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Ann Rev Microbiol 1990; 44 : 649-88.
7. Chungue E, Deubel V, Cassar O, Laille M, Martin PMV. Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia. J Gen Virol 1993; 74 : 2765-70.
8. Deubel V, Kinney RM, Trent DW. Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus: Jamaica genotype. Virology 1986; 155 : 365-77.
9. Domingo E, Holland JJ. Mutation rates and rapid evolution of RNA viruses. In: Morse SS, ed. The Evolutionary Biology of Viruses. New York: Raven Press, 1994: 161-84.
10. Duangchanda S, Tanaka M, Morita K, Rojanasuphot S, Igarashi A. Comparative nucleotide and deduced amino acid sequence of the envelope glycoprotein gene among three dengue virus type 2 strains isolated from patients with different disease severities in Maha Sarakham, Northeast Thailand. Southeast Asian J Trop Med Public Health 1994; 25 : 243-51.
11. Evans DMA, Dunn G, Minor PD, et al. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 1985; 314 : 548-50.
12. George R, Laim CK, Chua CT, et al. Unusual clinical manifestations of dengue virus infection. Southeast Asian J Trop Med Public Health 1988; 19 : 585-90.
13. Hahn CS, Dalrymple JM, Strauss JH, Rice CM. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci USA 1987; 84 : 2019-23.
14. Hahn YS, Galler R, Hunkapiller T, Dalrymple JM, Strauss JH, Strauss EG. Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology 1988; 162 : 167-80.
15. Halstead SB. Immunological parameters of togavirus disease syndromes. In: Schlesinger RW, ed. Togaviruses: Biology, Structure, Replication. New York: Academic Press, 1980: 107-73.
16. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239 : 476-81.
17. Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 1982; 31 : 830-6.
18. Igarashi A. Isolation of Singh's Aedes albopictus cell clone sensitive to dengue and chikungunya viruses. J Gen Virol 1978; 40 : 531-44.
19. Ishimine T, Tadano M, Fukunaga F, Okuno Y. An improved micromethod for infectivity assays and neutralization tests of dengue viruses. Biken J 1987; 30 : 39-44.
20. Jennings AD, Gibson CA, Miller BR, et al. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis 1994; 169 : 512-8.
21. Khin MM, Jirakanjanakit N, Yoksan S, Bhamarapravati N. Infection, dissemination, transmission, and biological attributes of dengue-2 PDK 53 candidate vaccine virus after oral infection in Aedes aegypti. Am J Trop Med Hyg 1994; 51 : 864-9.
22. Lai CJ, Zhao B, Hori H, Bray M. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci USA 1991; 88 : 5139-43.
23. Lee E, Gubler DJ, Weir RC, Dalgarno L. Genetic and biological differentiation of dengue 3 isolates obtained from clinical cases in Java, Indonesia, 1976-1978. Arch Virol 1993; 133 : 113-25.
24. Lewis JA, Chang GJ, Lanciotti RS, Kinney RM, Mayer LW, Trent DW. Phylogenetic relationships of dengue-2 viruses. Virology 1993; 197 : 216-24.
25. Mandl CW, Guirakhoo F, Holzmann H, Heinz FX, Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol 1989; 63 : 564-71.
26. Monath TP. Pathobiology of the flaviviruses. In: Schlesinger S, Schlesinger MJ, eds. The Togaviridae and Flaviviridae. New York: Plenum Press, 1986: 375-440.
27. Nimmannitya S. Clinical manifestations of dengue/dengue hemorrhagic fever. In: Thongcharoen P, ed. Monograph on Dengue/Dengue hemorrhagic Fever. WHO, 1993: 48-54.
28. Nitayaphan S, Grant GA, Chang GJJ, Trent DW. Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivatives, SA-14-14-2. Virology 1990; 177 : 541-52.
29. Okuno Y, Sasao F, Fukunaga T, Fukai K. An application of PAP (peroxidase-anti-peroxidase) staining technique for the rapid titration of dengue virus type 4 infectivity. Biken J 1977; 20 : 29-33.
30. Pletnev AG, Bray M, Huggins J, Lai CJ. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci USA 199; 289 : 10532-6.
31. Pletnev AG, Bray M, Lai CJ. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol 1993; 67 : 4956-63.
32. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2A° resolution. Nature 1995; 375 : 291-8.
33. Rico-Hesse R. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 1990; 174 : 479-93.
34. Sangkavipha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1980; 120 : 653-69.
35. Sittisombut N, Sistayanarain A, Cardosa MJ, et al. Possible genetic bottleneck occurred in dengue serotype 2 viruses between the 1980 and 1987 epidemic seasons in Bangkok, Thailand. 1996. Manuscript submitted.
36. Steinhauer DA, Holland JJ. Rapid evolution of RNA viruses. Ann Rev Microbiol 1987; 41 : 409-33.
37. Trent DW, Grant JA, Monath TP, Manske CL, Corina M, Fox GE. Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology 1989; 172: 523-35.
38. Trent DW, Grant JA, Rosen L, Monath TP. Genetic variation among dengue 2 viruses of different geographic origin. Virology 1983; 128 : 271-84.
39. Viputtikul K, Kanjanahaluethai A, Maneekarn N, Sittisombut N, Improvements and comparison of peroxidase-anti-peroxidase staining method with plaque assay for the titration of dengue type 2 virus. Chiang Mai Med Bull 1993; 32 : 123-8.
40. Walker PJ, Henchal EA, Blok J, et al. Variation in dengue type 2 viruses isolated in Bangkok during 1980. J Gen Virol 1988; 69 : 591-602.
41. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. Geneva: WHO, 1986: 1-39.